Íæż½ã½ã

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
Genetic Engineering and Biotechnology News12:37T-Cells Cancer Cancer Treatment
Pharmaceutical Technology05:40T-Cells Cancer Treatment FDA
News-Medical.Net15:20T-Cells Cancer Treatment Cancer
British Society for Haematology04:10T-Cells Cancer Cancer Treatment
Clinical Trials Arena06:44T-Cells
Medpage Today01:11T-Cells Cancer Cancer Treatment
pharmaphorum03:50Biotechnology Pharma Biotech
Yesterday
GlobeNewswire (Press Release)12:19 19-Sep-24
GlobeNewswire (Press Release)09:34 19-Sep-24
PR Newswire (Press Release)08:36 19-Sep-24
Newswise (Press Release)06:12 19-Sep-24
Newswise (Press Release)06:12 19-Sep-24
In the last 7 days
OncLive13:25 18-Sep-24
Genetic Engineering and Biotechnology News12:37 18-Sep-24
PR Newswire (Press Release)08:36 18-Sep-24
PR Newswire (Press Release)06:23 18-Sep-24
Pharmaceutical Technology05:40 17-Sep-24
PR Newswire (Press Release)17:35 16-Sep-24
PR Newswire (Press Release)08:05 16-Sep-24
PR Newswire (Press Release)07:03 16-Sep-24
British Society for Haematology04:10 16-Sep-24
In the last month
PR Newswire (Press Release)21:33 12-Sep-24
News-Medical.Net15:20 12-Sep-24
Medical Xpress12:47 12-Sep-24
Newswise (Press Release)11:15 12-Sep-24
GlobeNewswire (Press Release)16:35 11-Sep-24
UPI10:15 11-Sep-24
NewsMax08:34 11-Sep-24
HealthDay05:52 11-Sep-24
GlobeNewswire (Press Release)16:03 9-Sep-24
Clinical Trials Arena06:44 9-Sep-24
pharmaphorum03:50 5-Sep-24
Medpage Today01:11 5-Sep-24
Medpage Today01:11 5-Sep-24
PR Newswire (Press Release)16:09 4-Sep-24
OncLive12:26 4-Sep-24
FierceBiotech08:11 4-Sep-24
Business Wire (Press Release)08:07 4-Sep-24
AsiaOne22:54 3-Sep-24
Medical Xpress16:00 3-Sep-24
Newswise (Press Release)12:27 3-Sep-24
Newswise (Press Release)12:16 3-Sep-24
Newswise (Press Release)11:58 3-Sep-24
Biopharma Reporter09:22 3-Sep-24
PR Newswire (Press Release)08:32 3-Sep-24
Drug Target Review05:07 29-Aug-24
Genetic Engineering and Biotechnology News12:32 28-Aug-24
GlobeNewswire (Press Release)09:34 28-Aug-24
Clinical Trials Arena06:57 28-Aug-24
Biopharma Reporter10:19 27-Aug-24
GlobeNewswire (Press Release)08:51 27-Aug-24
Manufacturing Chemist07:47 27-Aug-24
AsiaOne06:10 27-Aug-24
Pharmacy Times13:52 26-Aug-24
GlobeNewswire (Press Release)08:35 26-Aug-24
Regeneron Pharmaceuticals (Press Release)07:02 26-Aug-24
Nature.com09:33 25-Aug-24
Seeking Alpha23:08 23-Aug-24
Scrip Pharma Intelligence12:09 23-Aug-24
GlobeNewswire (Press Release)01:06 23-Aug-24
Biopharma Reporter10:34 22-Aug-24
PRWeb (Press Release)08:40 22-Aug-24
PR Newswire (Press Release)07:47 21-Aug-24
view more headlines
19 Sep 12:19

About our CAR-T news

Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.


Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.